Listing Of MNC Arms In India Has Been Rough Ride With Stray Sparks Of Hope
This article was originally published in PharmAsia News
Executive SummaryMUMBAI - As Pfizer Inc. looks to potentially spin-off its emerging markets unit and analysts talk openly about spin-outs for other companies as well, industry watchers may want to take a closer look at India, where several Big Pharma have had separately listed subsidiaries for decades
You may also be interested in...
AstraZeneca Restores Supply Of Key Recalled Products In India; Plans To Outsource Manufacturing And Launch More Drugs
After being battered by a government probe and voluntary recalls earlier this year, the company appears to be gearing up for a stronger presence in India.